More on WVE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.81 |
|
|||
| Open | $5.92 | ||||
| 52 Wk High | $38.50 | ||||
| 52 Wk Low | $8.95 | ||||
| Day High | $6.12 | ||||
| Day Low | $5.88 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 904,758 | ||||
- Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
- Wave Life Sciences schedules Singapore court hearing for US redomiciliation
- Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
- Form 8-K Wave Life Sciences Ltd. For: Jun 22
- Wave Life Sciences starts Phase 2a obesity trial for WVE-007 drug
- Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases
- H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
- Eco Wave Power featured in second NVIDIA keynote within three months
- Eco Wave Power Featured for Second Time in NVIDIA Founder and CEO Jensen Huang's GTC Keynote, as Company Advances Taiwan Wave Energy Project
- Wave Life Sciences to Present at Upcoming Investor Conferences
Entities mentioned with WVE
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- Dividend | View Related Stories »
- Show More...
